Jasper Therapeutics Inc (NAS:JSPR) Stock News, Headlines & Updates
Jasper Therapeutics Inc Stock News from GuruFocus
- 1
Jun 16, 2025
JSPR: Promising Results from Phase 1b/2a Study of Briquilimab | JSPR Stock News
GuruFocus News • 7:45pm
Jun 14, 2025
Jasper Therapeutics Reports Positive Data from 180mg Cohort in SPOTLIGHT Study of Briquilimab in Chronic Inducible Urticaria
GlobeNewswire • 11:00am
Jasper Therapeutics Reports Positive Data from 180mg Cohort in SPOTLIGHT Study of Briquilimab in Chronic Inducible Urticaria
Marketwired • 10:00am
Jasper Therapeutics Reports Positive Data from 180mg Cohort in SPOTLIGHT Study of Briquilimab in Chronic Inducible Urticaria | JSPR Stock News
GuruFocus News • 9:15am
Jun 03, 2025
Jasper Therapeutics Announces Briquilimab Presentations at the European Academy of Allergy and Clinical Immunology (EAACI) Annual Congress
Marketwired • 8:00am
Jasper Therapeutics Announces Briquilimab Presentations at the European Academy of Allergy and Clinical Immunology (EAACI) Annual Congress | JSPR Stock News
GuruFocus News • 7:17am
May 15, 2025
Jasper Therapeutics (JSPR) Price Target Lowered by Oppenheimer | JSPR Stock News
GuruFocus News • 1:35pm
Oppenheimer Adjusts Price Target for Jasper Therapeutics (JSPR) | JSPR Stock News
GuruFocus News • 6:53am
May 14, 2025
Jasper Therapeutics to Present at Upcoming Investor Conferences
Marketwired • 4:00pm
Jasper Therapeutics to Present at Upcoming Investor Conferences | JSPR Stock News
GuruFocus News • 3:51pm
May 13, 2025
UBS Maintains Buy Rating for Jasper Therapeutics (JSPR) Despite Price Target Adjustment | JSPR Stock News
GuruFocus News • 11:35am
JSPR Price Target Adjusted by UBS Amidst Upcoming Clinical Updates | JSPR Stock News
GuruFocus News • 8:00am
May 12, 2025
Jasper (JSPR) Advances Briquilimab with Promising Trial Results | JSPR Stock News
GuruFocus News • 4:46pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news